 Shares of ADGI stock are down more than 75 after new data showed its ADG-20 lacked effectiveness against the omicron variant. The post ADGI Stock Alert: The Omicron Variant Just Sent Adagio Therapeutics Plunging appeared first on InvestorPlace. 